Early Modulation of Circulating MicroRNAs Levels in HER2-Positive Breast Cancer Patients Treated with Trastuzumab-Based Neoadjuvant Therapy (Q89835415)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32085669 AND SRC:MED&resulttype=core&format=json

8 April 2020

title

Early Modulation of Circulating MicroRNAs Levels in HER2-Positive Breast Cancer Patients Treated with Trastuzumab-Based Neoadjuvant Therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32085669 AND SRC:MED&resulttype=core&format=json

8 April 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32085669 AND SRC:MED&resulttype=core&format=json

8 April 2020

Marco Silvestri

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32085669 AND SRC:MED&resulttype=core&format=json

8 April 2020

Florentine Hilbers

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32085669 AND SRC:MED&resulttype=core&format=json

8 April 2020

Evandro de Azambuja

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32085669 AND SRC:MED&resulttype=core&format=json

8 April 2020

Paolo Nuciforo

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32085669 AND SRC:MED&resulttype=core&format=json

8 April 2020

Maria Grazia Daidone

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32085669 AND SRC:MED&resulttype=core&format=json

8 April 2020

16

Anne Vincent-Salomon

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32085669 AND SRC:MED&resulttype=core&format=json

8 April 2020

author name string

Serena Di Cosimo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32085669 AND SRC:MED&resulttype=core&format=json

8 April 2020

Valentina Appierto

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32085669 AND SRC:MED&resulttype=core&format=json

8 April 2020

José Baselga

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32085669 AND SRC:MED&resulttype=core&format=json

8 April 2020

Martine Piccart

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32085669 AND SRC:MED&resulttype=core&format=json

8 April 2020

Jens Huober

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32085669 AND SRC:MED&resulttype=core&format=json

8 April 2020

Miguel Izquierdo

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32085669 AND SRC:MED&resulttype=core&format=json

8 April 2020

Lorena de la Pena

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32085669 AND SRC:MED&resulttype=core&format=json

8 April 2020

Michael Untch

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32085669 AND SRC:MED&resulttype=core&format=json

8 April 2020

Lajos Pusztai

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32085669 AND SRC:MED&resulttype=core&format=json

8 April 2020

Kathleen Pritchard

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32085669 AND SRC:MED&resulttype=core&format=json

8 April 2020

Fraser Symmans

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32085669 AND SRC:MED&resulttype=core&format=json

8 April 2020

Giovanni Apolone

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32085669 AND SRC:MED&resulttype=core&format=json

8 April 2020

Filippo G de Braud

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32085669 AND SRC:MED&resulttype=core&format=json

8 April 2020

Marilena V Iorio

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32085669 AND SRC:MED&resulttype=core&format=json

8 April 2020

Paolo Verderio

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32085669 AND SRC:MED&resulttype=core&format=json

8 April 2020

publication date

18 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32085669 AND SRC:MED&resulttype=core&format=json

International Journal of Molecular Sciences

8 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32085669 AND SRC:MED&resulttype=core&format=json

8 April 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32085669 AND SRC:MED&resulttype=core&format=json

8 April 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32085669 AND SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

8 April 2020

copyright license

start time

18 February 2020

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

12 December 2020

Regulation of life and death by the zinc finger transcription factor Egr-1.

1 reference

12 December 2020

The functions of animal microRNAs

1 reference

12 December 2020

Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action

1 reference

12 December 2020

Role of cyclic AMP response element-binding protein in insulin-like growth factor-i receptor up-regulation by sex steroids in prostate cancer cells

1 reference

12 December 2020

Global microRNA expression profiling identifies MiR-210 associated with tumor proliferation, invasion and poor clinical outcome in breast cancer

1 reference

12 December 2020

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial

1 reference

12 December 2020

Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients

1 reference

12 December 2020

A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1.

1 reference

12 December 2020

MiR-148a inhibits angiogenesis by targeting ERBB3.

1 reference

12 December 2020

Predictive Factors of Response in HER2-Positive Breast Cancer Treated by Neoadjuvant Therapy

1 reference

12 December 2020

1 reference

12 December 2020

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

1 reference

12 December 2020

NqA: an R-based algorithm for the normalization and analysis of microRNA quantitative real-time polymerase chain reaction data

1 reference

12 December 2020

GPER mediated estradiol reduces miR-148a to promote HLA-G expression in breast cancer

1 reference

12 December 2020

Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparquinto trial.

1 reference

12 December 2020

The p85 regulatory subunit of PI3K mediates cAMP-PKA and insulin biological effects on MCF-7 cell growth and motility.

1 reference

12 December 2020

PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (her2) therapy in primary HER2-overexpressing breast cancer.

1 reference

12 December 2020

High HER2 expression correlates with response to the combination of lapatinib and trastuzumab.

1 reference

12 December 2020

Molecular pathways: microRNAs, cancer cells, and microenvironment

1 reference

12 December 2020

Regulatory circuit of PKM2/NF-κB/miR-148a/152-modulated tumor angiogenesis and cancer progression

1 reference

12 December 2020

MicroRNA biogenesis pathways in cancer

1 reference

12 December 2020

Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab: A Secondary Analysis of the NeoALTTO Trial

1 reference

12 December 2020

Seribantumab, an Anti-ERBB3 Antibody, Delays the Onset of Resistance and Restores Sensitivity to Letrozole in an Estrogen Receptor-Positive Breast Cancer Model

1 reference

12 December 2020

Mechanisms of resistance and sensitivity to anti-HER2 therapies in HER2 breast cancer

1 reference

12 December 2020

MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer

1 reference

12 December 2020

The Role of Mir-148a in Cancer

1 reference

12 December 2020

A miRNA-based signature predicts development of disease recurrence in HER2 positive breast cancer after adjuvant trastuzumab-based treatment

1 reference

12 December 2020

Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers.

1 reference

12 December 2020

Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage.

1 reference

12 December 2020

Prediction of key genes and pathways involved in trastuzumab-resistant gastric cancer

1 reference

12 December 2020

miRWalk: An online resource for prediction of microRNA binding sites

1 reference

12 December 2020

Current and future perspectives of liquid biopsies in genomics-driven oncology

1 reference

12 December 2020

The latest progress on miR-374 and its functional implications in physiological and pathological processes

1 reference

12 December 2020

Liquid biopsy and minimal residual disease - latest advances and implications for cure

1 reference

12 December 2020

Plasma miRNA Levels for Predicting Therapeutic Response to Neoadjuvant Treatment in HER2-positive Breast Cancer: Results from the NeoALTTO Trial

1 reference

12 December 2020

miRNA-148a-3p Regulates Immunosuppression in DNA Mismatch Repair-Deficient Colorectal Cancer by Targeting PD-L1

1 reference

12 December 2020

Identifiers

DOI

10.3390/IJMS21041386

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32085669 AND SRC:MED&resulttype=core&format=json

8 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32085669 AND SRC:MED&resulttype=core&format=json

8 April 2020

PubMed publication ID

32085669

1 reference